Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
26.50
-0.14 (-0.53%)
At close: Jul 2, 2026, 4:00 PM EDT
25.99
-0.51 (-1.92%)
After-hours: Jul 2, 2026, 7:21 PM EDT
Alumis Market Cap
Alumis has a market cap or net worth of $3.38 billion as of July 2, 2026. Its market cap has increased by 1,963.09% in one year.
Market Cap
3.38B
Enterprise Value
2.84B
1-Year Change
1,963.09%
Ranking
Category
Stock Price
$26.50
Market Cap Chart
Since the IPO on June 28, 2024, Alumis's market cap has increased from $901.92M to $3.38B, an increase of 274.60%. That is a compound annual growth rate of 92.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 3.38B | 231.59% |
| Dec 31, 2025 | 1.02B | 138.26% |
| Dec 31, 2024 | 427.64M | -52.59% |
| Jun 28, 2024 | 901.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Catalyst Pharmaceuticals | 3.85B |
| Arcus Biosciences | 3.81B |
| Dyne Therapeutics | 3.81B |
| Structure Therapeutics | 3.80B |
| Parabilis Medicines | 3.77B |
| IDEAYA Biosciences | 3.58B |
| Enliven Therapeutics | 3.48B |
| Beam Therapeutics | 3.46B |